# Adjuvant Post-Tamoxifen Exemestane Trial

> **NCT00810706** · PHASE3 · TERMINATED · sponsor: **Hellenic Breast Surgeons Society** · enrollment: 448 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** exemestane

## Key facts

- **NCT ID:** NCT00810706
- **Lead sponsor:** Hellenic Breast Surgeons Society
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 448 (ACTUAL)
- **Why stopped:** Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole)
- **Last updated:** 2008-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810706, "Adjuvant Post-Tamoxifen Exemestane Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00810706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*